“香港 HPV 疫苗第一股” 瑞科生物首日上市逆勢收漲 1.81%

格隆匯
2022.03.31 08:24
大市整體下跌之際，瑞科生物 (2179.HK) 今日首日上市逆勢收漲 1.81% 報 25.25 港元，市值 121 億港元。此次 IPO，揚子江藥業集團、嘉實國際和紅杉中國作為公司的基石投資人，基石認購比例超過 50%。此前，公司曾獲君聯資本、LYFE Capital、東方富海、沃盈資本、紅杉中國、清池資本、淡馬錫等眾多知名投資機構的青睞。此次成功在港上市，成為 “香港 HPV 疫苗第一股”、“香港新型佐劑疫苗第一股”。
Source: 格隆匯 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.